Free Trial

Perrigo (NYSE:PRGO) EVP Abigail Lennox Purchases 1,255 Shares

Perrigo logo with Medical background

Key Points

  • Abigail Lennox, EVP of Perrigo, purchased **1,255 shares** of the company's stock at an average price of $22.41 per share, totaling **$28,124.55**.
  • Perrigo recently reported **earnings per share of $0.57**, missing estimates by $0.02, with revenues of **$1.06 billion** for the quarter.
  • The company declared a **quarterly dividend of $0.29 per share**, which will be paid on **September 16th**, providing an annualized yield of **5.2%**.
  • MarketBeat previews top five stocks to own in November.

Perrigo Company plc (NYSE:PRGO - Get Free Report) EVP Abigail Lennox purchased 1,255 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The shares were bought at an average price of $22.41 per share, for a total transaction of $28,124.55. Following the acquisition, the executive vice president directly owned 1,255 shares in the company, valued at $28,124.55. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

Perrigo Trading Down 2.3%

NYSE:PRGO traded down $0.52 during midday trading on Monday, hitting $21.76. 1,654,591 shares of the company traded hands, compared to its average volume of 1,424,538. The firm's fifty day moving average is $24.91 and its 200-day moving average is $26.02. Perrigo Company plc has a 12-month low of $21.03 and a 12-month high of $30.93. The firm has a market capitalization of $2.99 billion, a P/E ratio of -37.51 and a beta of 0.48. The company has a current ratio of 2.32, a quick ratio of 1.24 and a debt-to-equity ratio of 0.81.

Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.57 earnings per share for the quarter, missing analysts' consensus estimates of $0.59 by ($0.02). Perrigo had a positive return on equity of 9.09% and a negative net margin of 1.86%.The business had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.08 billion. During the same quarter in the previous year, the business earned $0.53 EPS. The business's revenue for the quarter was down .9% on a year-over-year basis. On average, sell-side analysts predict that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 29th will be paid a $0.29 dividend. The ex-dividend date is Friday, August 29th. This represents a $1.16 dividend on an annualized basis and a yield of 5.3%. Perrigo's dividend payout ratio (DPR) is presently -200.00%.

Hedge Funds Weigh In On Perrigo

Institutional investors have recently made changes to their positions in the company. American Assets Inc. bought a new stake in Perrigo during the fourth quarter valued at about $386,000. BNP Paribas Financial Markets boosted its position in Perrigo by 80.7% during the fourth quarter. BNP Paribas Financial Markets now owns 207,717 shares of the company's stock valued at $5,340,000 after purchasing an additional 92,780 shares in the last quarter. Baird Financial Group Inc. boosted its position in Perrigo by 8.8% during the fourth quarter. Baird Financial Group Inc. now owns 13,029 shares of the company's stock valued at $335,000 after purchasing an additional 1,053 shares in the last quarter. Nomura Holdings Inc. bought a new stake in Perrigo during the fourth quarter valued at about $465,000. Finally, Quantinno Capital Management LP boosted its position in Perrigo by 687.2% during the fourth quarter. Quantinno Capital Management LP now owns 155,033 shares of the company's stock valued at $3,986,000 after purchasing an additional 135,338 shares in the last quarter. Hedge funds and other institutional investors own 95.91% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on PRGO. Canaccord Genuity Group reduced their target price on Perrigo from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. JPMorgan Chase & Co. reduced their target price on Perrigo from $38.00 to $35.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Finally, Wall Street Zen upgraded Perrigo from a "hold" rating to a "buy" rating in a research note on Friday, September 5th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $33.00.

Check Out Our Latest Stock Report on PRGO

Perrigo Company Profile

(Get Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Featured Stories

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.